MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit. (October 2020) - Sampson, J.; Achrol, A.S.; Aghi, M.K.; Bankiewicz, K.; Bexon, M.; Brem, S.; Brenner, A.; Chowdhary, S.; Coello, M.; Ellingson, B.M.; Floyd, J.R.; Han, S.; et al.